T
455
vs
H
Hang Seng (Hong Kong)
Over the past 12 months, Tianda Pharmaceuticals Ltd has underperformed Hang Seng (Hong Kong), delivering a return of -31% compared to the Hang Seng (Hong Kong)'s +16% growth.
Stocks Performance
455 vs Hang Seng (Hong Kong)
Performance Gap
455 vs Hang Seng (Hong Kong)
Performance By Year
455 vs Hang Seng (Hong Kong)
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Tianda Pharmaceuticals Ltd
Glance View
Tianda Pharmaceuticals Ltd. operates as an investment holding company, which engages in the research and development, manufacture and sale of pharmaceutical, biotechnology and healthcare products. The company employs 714 full-time employees The main businesses of the Company include the research and development, production and sales of pharmaceutical, biotechnology and healthcare products. Its products include cardio-cerebrovascular drugs, paediatric drugs, anti-flu and respiratory system drugs, anti-infection drugs, medicines for drug addicts and other pharmaceutical products, as well as healthcare products under the Herb Valley series. The firm operates businesses in Hong Kong, China and Australia.